Related Experiment Video
Updated: Apr 19, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Novel medical strategies combating nonmelanoma skin cancer
Prasan R Bhandari1, Varadraj V Pai2
1Department of Pharmacology, Shri Dharmasthala Manjunatheshwara College of Medical Sciences and Hospital, Sattur, Dharwad, Karnataka, India.
Abstract:
The incidence of nonmelanoma skin cancer (NMSC) continues to rise, partly because of aging, the frequency of early childhood sunburns, and sporadic extreme recreational sun exposure. A nonsurgical approach to selected cutaneous malignancy could possibly reduce the cost as well as morbidity of surgical treatment for NMSC. There has been growing interest in isolating compounds that could suppress or reverse the biochemical changes necessary for cutaneous malignancies to progress by pharmacologic intervention. By targeting diverse pathways recognized as important in the pathogenesis of nonmelanoma skin cancers, a combination approach with multiple agents or addition of chemopreventative agents to topical sunscreens may offer the potential for novel and synergistic therapies in treating nonmelanoma skin cancer. This preliminary information will expand to include more therapeutic options for NMSC in the future.
Insights
Nonmelanoma skin cancer (NMSC) is increasing. Researchers are exploring nonsurgical treatments, including pharmacologic interventions and combination therapies, to combat rising NMSC incidence and improve patient outcomes.
Area of Science:
- Dermatology
- Oncology
- Pharmacology
Background:
- The incidence of nonmelanoma skin cancer (NMSC) is rising due to factors like aging, childhood sunburns, and excessive sun exposure.
- Surgical treatment for NMSC can be costly and lead to significant morbidity.
- There is a growing need for effective, less invasive therapeutic strategies for NMSC.
Purpose of the Study:
- To explore nonsurgical approaches for treating nonmelanoma skin cancer.
- To investigate pharmacologic interventions targeting key pathways in NMSC pathogenesis.
- To evaluate the potential of combination therapies and chemopreventative agents for NMSC treatment.
Main Methods:
- Review of current research on NMSC pathogenesis and treatment options.
- Identification of biochemical pathways involved in cutaneous malignancy progression.
- Exploration of pharmacologic agents and combination strategies for NMSC.
Main Results:
- Nonsurgical approaches may reduce the cost and morbidity associated with NMSC treatment.
- Targeting specific pathways in NMSC pathogenesis offers potential therapeutic avenues.
- Combination therapies and chemopreventative agents added to sunscreens show promise for synergistic effects.
Conclusions:
- Pharmacologic interventions and combination therapies represent promising avenues for novel NMSC treatments.
- Further research into these nonsurgical approaches could lead to expanded therapeutic options for NMSC.
- Future studies will focus on developing and validating these alternative NMSC treatment strategies.
More Related Videos
11:02The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
Published on: August 3, 2011
09:37Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...